Stroke remains a leading cause of morbidity and mortality worldwide, leading to the development of efficient and evidence-based management strategies. Echocardiography is a crucial diagnostic tool for identifying cardiac sources of embolism, particularly in cardioembolic and cryptogenic strokes, yet its routine use in all stroke patients remains controversial. While evidence-based guidelines recommend a patient-specific approach, rigid hospital quality metrics have incentivized widespread echocardiography, even in low-yield cases such as large artery atherosclerotic strokes. This disconnect raises concerns regarding cost-effectiveness, resource allocation, and potential over-testing, delaying discharges and prolonging hospital length of stay. A more tailored approach, focusing on guideline-driven indications, is necessary to optimize stroke care. Future research should refine diagnostic criteria and align quality metrics with evidence-based practices to ensure high-value, patient-centered stroke management.
Tesoro et al. (2026) studied this question.